Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
4
×
detroit blog main
detroit top stories
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amgen
biogen
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
drug prices
eli lilly
generic drugs
What
bio
roundup
crispr
drug
acquisitions
albert
alliance
appetite
approval
biggest
biogen’s
biopharmaceutical
black
bourla
bread
bristol
butter
buy
buyout
calls
cancer
cash
ceo
changing
color
companies
company
convo
days
diabetes
diamond’s
drugs
earlier
eli
failures
future
giant
grabbed
growing
hasn’t
Language
unknown
unset
Current search:
glaxosmithkline
×
deals
×
" seattle blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More